Tau蛋白介导血管风险与Aβ对认知下降的协同影响
研究纳入175名认知未受损老年人,基线用FHS-CVD评分评估血管风险、PiB-PET测Aβ负荷,纵向Flortaucipir PET测下颞叶皮层Tau累积(3.6±1.5年),认知随访7.0±2.0年。基线FHS-CVD与Aβ对下颞叶Tau累积存在显著交互作用(p=0.004),Tau累积介导了33%的FHS-CVD与Aβ交互对认知下降的关联。作者认为血管风险与亚阈值Aβ交互促进认知下降,部分通过加速早期新皮层Tau累积实现。
要点
- 基线FHS-CVD与Aβ对下颞叶Tau累积存在显著交互作用(p=0.004)。
- 即使Aβ负荷低于传统淀粉样蛋白阳性阈值,该交互作用仍存在。
- 下颞叶Tau累积介导33%的FHS-CVD与Aβ交互对认知下降的关联。
核心结论
- 血管风险与亚阈值Aβ交互促进认知下降,部分通过加速早期新皮层Tau累积实现。
- 作者认为降低血管风险(尤其治疗高血压和肥胖)可减轻Aβ相关Tau病理并减少晚年认知下降。
研究设计与样本
- 研究纳入175名认知未受损老年人(年龄70.5±8.0岁)。
- 基线血管风险用Framingham心脏研究一般心血管疾病风险评分(FHS-CVD)量化,基线Aβ负荷用匹兹堡化合物B正电子发射断层扫描(PET)测量。
- Tau负荷用Flortaucipir PET纵向测量(3.6±1.5年),聚焦下颞叶皮层(ITC)。
- 认知用临床前阿尔茨海默病认知复合量表纵向评估(7.0±2.0年)。
- 用线性混合效应模型检验基线血管风险与Aβ对纵向ITC Tau的交互效应,并用调节中介分析判断Tau累积是否介导FHS-CVD×Aβ对认知下降的效应。
主要发现
- 基线FHS-CVD升高与Aβ对ITC Tau累积存在显著交互作用(p=0.004),即使在Aβ负荷低于传统淀粉样蛋白阳性阈值的个体中亦然。
- 收缩压升高和体重指数升高分别与Aβ对纵向Tau存在独立交互作用(两者p<0.0001)。
- ITC Tau累积介导了FHS-CVD与Aβ交互对认知下降关联的33%。
临床怎么用
- 作者认为降低血管风险、尤其治疗高血压和肥胖,可减轻Aβ相关Tau病理并减少晚年认知下降。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Elevated vascular risk and beta-amyloid (Aβ) burden have been synergistically associated with cognitive decline in preclinical Alzheimer's disease (AD), although the underlying mechanisms remain unclear. We examined whether accelerated longitudinal tau accumulation mediates the vascular risk-Aβ interaction on cognitive decline. METHODS: We included 175 cognitively unimpaired older adults (age 70.5 ± 8.0 years). Baseline vascular risk was quantified using the office-based Framingham Heart Study general cardiovascular disease risk score (FHS-CVD). Baseline Aβ burden was measured with Pittsburgh Compound-B positron emission tomography (PET). Tau burden was measured longitudinally (3.6 ± 1.5 years) with Flortaucipir PET, focusing on inferior temporal cortex (ITC). Cognition was assessed longitudinally (7.0 ± 2.0 years) using the Preclinical Alzheimer's Cognitive Composite. Linear mixed effects models examined the interactive effects of baseline vascular risk and Aβ on longitudinal ITC tau. Additionally, moderated mediation was used to determine whether tau accumulation mediated the FHS-CVD*Aβ effect on cognitive decline. RESULTS: We observed a significant interaction between elevated baseline FHS-CVD and Aβ on greater ITC tau accumulation (p = 0.004), even in individuals with Aβ burden below the conventional threshold for amyloid positivity. Examining individual vascular risk factors, we found elevated systolic blood pressure and body mass index showed independent interactions with Aβ on longitudinal tau (both p < 0.0001). ITC tau accumulation mediated 33% of the interactive association of FHS-CVD and Aβ on cognitive decline. INTERPRETATION: Vascular risks interact with subthreshold levels of Aβ to promote cognitive decline, partially by accelerating early neocortical tau accumulation. Our findings support vascular risk reduction, especially treating hypertension and obesity, to attenuate Aβ-related tau pathology and reduce late-life cognitive decline. ANN NEUROL 2022;92:745-755.
引用
- Yau WW, Shirzadi Z, Yang HS, et al. Tau Mediates Synergistic Influence of Vascular Risk and Aβ on Cognitive Decline. Ann Neurol. 2022. PMID: 35880989. doi:10.1002/ana.26460
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。